Qsemble Capital Management »

Cytokinetics shares owned by Qsemble Capital Management

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Qsemble Capital Management from 13F filings

Historical chart of Qsemble Capital Management investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Qsemble Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Qsemble Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $333k 6.1k 54.96
2025-03-31 $315k 7.8k 40.19
2024-12-31 $261k 5.5k 47.04